StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research note issued to investors on Saturday. The firm issued a hold rating on the stock.
Separately, Benchmark reiterated a “speculative buy” rating and set a $1.25 price target on shares of Milestone Scientific in a report on Wednesday, November 20th.
Get Our Latest Analysis on MLSS
Milestone Scientific Stock Performance
Insiders Place Their Bets
In other news, Director Leonard Osser sold 107,984 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total transaction of $100,425.12. Following the completion of the sale, the director now directly owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This trade represents a 2.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 24.75% of the stock is currently owned by insiders.
Hedge Funds Weigh In On Milestone Scientific
Institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC grew its holdings in Milestone Scientific by 6.4% during the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after purchasing an additional 31,572 shares during the period. Y Intercept Hong Kong Ltd bought a new stake in shares of Milestone Scientific in the third quarter valued at $48,000. Finally, World Investment Advisors LLC purchased a new position in shares of Milestone Scientific during the 3rd quarter valued at $91,000. Institutional investors own 5.79% of the company’s stock.
Milestone Scientific Company Profile
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
See Also
- Five stocks we like better than Milestone Scientific
- What is the Nasdaq? Complete Overview with History
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- When to Sell a Stock for Profit or Loss
- Top 3 ETFs to Hedge Against Inflation in 2025
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.